- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 233 results
Conference
March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
Conference
March 8, 2023
California Life Sciences Summit
Webinar
February 23, 2023
MDLs: Judges, Defendants and Plaintiffs Too – Who Is Buzzing About What?
Speaking Engagement
January 25, 2023
Eva Temkin to Speak on Food and Drug Law Institute Webinar
Webinar
January 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
Webinar
January 19, 2023
A New Year, A New Day - What’s Next for Healthcare Policy and Oversight in the New Congress
Speaking Engagement
December 16, 2022
Ulf Grundmann, Elisabeth Kohoutek to Speak at Hebrew University of Jerusalem’s BioMED MBA Program
Webinar
December 8, 2022
Physician Practice Acquisitions Roundtable: Considerations for Negotiating on Behalf of Buyers and Sellers
Speaking Engagement
December 2, 2022
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA Program
Speaking Engagement
November 30, 2022
Lisa Dwyer to Speak on Food and Drug Law Institutes Virtual Event
Webinar
November 30, 2022
Are You Prepared? FDA’s Proposed Rules to Modify Protection of Human Subjects and IRB Oversight
Webinar
November 17, 2022
State Attorneys General Election Results and What to Expect in 2023